[1] Birnkrant DJ, Bushby K, Bann CM, et al.Diagnosis and management of Duchenne muscular dystrophy, part1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management[J].Lancet Neurol, 2018, 17(3):251-267. [2] Rodríguez-Cruz M, Sanchez R, Escobar RE, et al.Evidence of insulin resistance and other metabolic alteration in boys with Duchenne or Becker muscular dystrophy[J].Int J Endocrinol, 2015, 2015:1-8. [3] David RW, Stasia H, Hugh JM, et al.Obesity and Endocrine Management of the patient with Duchenne muscular dystrophy[J].Pediatrics, 2018, 142(Suppl 2):43-52. [4] Haddad L, Achadi E, Bendech MA, et al.The global nutrition report 2014: actions and accountability to accelerate the world's progress on nutrition[J].J Nutr, 2015, 145(4):663-671. [5] Barja S, Perez R.Clinical assessment underestimates fat mass and overestimates resting energy expenditure in children with neuromuscular diseases[J].Clin Nutr ESPEN, 2016, 15:11-15. [6] Elliott SA, Davidson ZE, Davies PS, et al.A bedside measure of body composition in Duchenne muscular dystrophy[J].Pediatr Neurol, 2015, 52(1):82-87. [7] 李辉, 季成叶, 宗心南, 等.中国0~18岁儿童、青少年体块指数的生长曲线[J].中华儿科杂志, 2009, 47(7):493-498. [8] Deurenberg P, Deurenberg YM, Staveren WA.Body mass index and percent body fat: A meta-analysis among different ethnic groups[J].Int J Obes Relat Metab Disord, 1998, 22(12):1164-1171. [9] Lamb MM, West NA, Ouyang L, et al.Corticosteroid treatment and growth patterns in ambulatory in males with Duchenne muscular dystrophy[J].J Pediatr, 2016, 173:207-213. [10] Crabtree NJ, Adams JE, Padidela R, et al.Growth, bone health & ambulatory status of boys with DMD treated with daily vs intermittent oral glucocorticoid regimen[J].Bone, 2018, 116:181-186.
[11] Barzegar M, Niknam E, Habibi P, et al.Bone mineral density and bone metabolism in patients with duchenne muscular dystrophy[J].Iran J Child Neurol, 2018, 12(1):77-83. [12] DelRocio Cruz-Guzman O, Rodriguez-Cruz M, Almeida-Bec erril T, et al.Muscle function and age are associated with loss of bone mineral density in Duchenne muscular dystrophy[J].Muscle Nerve, 2019, 54(9):417-421. [13] Bernabe-Garcia M, Rodriguez-Cruz M, Atilano S, et al.Body composition and body mass index in Duchenne muscular dystrophy: Role of dietary intake[J].Muscle Nerve, 2019, 59(3):295-302. [14] Davis J, Samuels E, Mullins L.Nutrition considerations inDuchenne muscular dystrophy[J].Nutr Clin Pract, 2015, 30(4):511-521. [15] Yiu EM, Kornberg AJ.Duchenne muscular dystrophy[J].J Paediatr Child Health, 2015, 51(8):759-764. [16] Saure C, Caminiti C, Weglinski J, et al.Energy expenditure, body composition, and prevalence of metabolic disorders in patients with Duchenne muscular dystrophy[J].Diabetes Metab Syndr, 2018, 12(2):81-85. [17] 张慧云, 李燕, 刘长云, 等.济南市4~6岁儿童体成分分析[J].中国儿童保健杂志, 2019, 27(05):554-557. [18] Pessolano FA, Súarez AA, Monteiro SG, et al.Nutritional assessment of patients with neuromuscular diseases[J].Am J Phys Med Rehabil, 2003, 82(3):182-185. [19] Mok E, Beghin L, Gachon P, et al.Estimating body composition in children with Duchenne muscular dystrophy:comparison of bioelectrical impedance analysis and skinfold-thickness measurement[J].Am J Clin Nutr, 2006, 83(1):65-69. [20] Davidson ZE, Ryan MM, Kornberg AJ, et al.Observations of body mass index in Duchenne muscualr dystrophy: a longitudinal study[J].Eur J Clin Nutr, 2014, 68(8):892-897. [21] Kyle UG, Bosaeus I, De Lorenzo AD, et al.Bioelectrical impedance analysis dpart II: utilization in clinical practic[J].Clin Nutr, 2004, 23(6):1430-1453. [22] Barbosa-Silva MC, Barros AJ.Bioelectrical impedance analysis in clinical practice: a new perspective on its use beyond body composition equations[J].Curr Opin Clin Nutr Metab Care, 2005, 8(3):311-317. |